|
|
|
| Please use the form below to log in. "Remeber me" function uses Cookies, please make sure this feature is not disabled in your browser settings. |
|
|
|
| If you lost your password please use the form provided below to get a new one. |
|
|
|
|
|
|
 |
Industry Events |
 |
Pharma Integrates 2021
16 November 2021, VIRTUAL CONFERENCE
Now in its tenth year, Pharma Integrates is a unique event bringing
together pharma and healthcare leaders across the Pharmaceutical
pipeline to address their needs, to share insights and create debate on
crucial topics that influence the future of patient outcomes.
More info >> |
|
 |
News and Press Releases |
 |
UK Medicines and Healthcare Products Regulatory Agency (MHRA) Issues an Early Access to Medicines Scheme (EAMS) Positive Scientific Opinion for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations
Feltham (Merck) – Merck announced today that the UK Medicines and
Healthcare Products Regulatory Agency (MHRA) has issued an Early Access
to Medicines Scheme (EAMS) positive scientific opinion for tepotinib
for the treatment of adult patients with advanced Non-Small Cell Lung
Cancer (NSCLC) harbouring mesenchymal-epithelial transition factor gene
(MET) exon 14 (METex14) skipping alterations.
More info >> |
|
|
